Aktis Oncology, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Aktis Oncology, Inc. (AKTS) is 16.33

According to Aktis Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 16.33. This represents a change of 24.50% compared to the average of 13.11 of the last 4 quarters.

Aktis Oncology, Inc. (AKTS) Historical Current Ratio (quarterly & annually)

How has AKTS Current Ratio performed in the past?

The mean historical Current Ratio of Aktis Oncology, Inc. over the last ten years is 16.13. The current 16.33 Current Ratio has changed 1.19% with respect to the historical average. Over the past ten years (40 quarters), AKTS's Current Ratio was at its highest in in the March 2026 quarter at 19.49. The Current Ratio was at its lowest in in the March 2025 quarter at 0.

Aktis Oncology, Inc. (AKTS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aktis Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aktis Oncology, Inc. (AKTS) Average Current Ratio

How has AKTS Current Ratio performed in the past?

The current Current Ratio of Aktis Oncology, Inc. (AKTS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aktis Oncology, Inc. (AKTS) Current Ratio vs. Peers

How is AKTS’s Current Ratio compared to its peers?

Aktis Oncology, Inc.’s Current Ratio is greater than Bicycle Therapeutics plc (12.09), greater than Akari Therapeutics, Plc (0.60), greater than Immunome, Inc. (15.08), greater than MacroGenics, Inc. (2.96), greater than Immunocore Holdings plc (4.47), less than Aura Biosciences, Inc. (16.82),

Build a custom stock screener for Aktis Oncology, Inc. (AKTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aktis Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aktis Oncology, Inc. (AKTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aktis Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.